Metformin vs mortality in hospitalized patients with type 2 diabetes & COVID-19 (n=4,462) – In-hospital mortality: 28.1% for metformin users 25.3% non-metformin group – Adjusting to make the toxin look good: 29.3% metformin 29.6% non-metformin https://
RT @FrontEndocrinol: New Research: Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVI…
New Research: Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVID-19: A multiracial, multiethnic, urban observational study: Introduction Diabetes mellitus is a common… https://t.co/7qU6fsZJip #Endocri